Daily Bulletin

Men's Weekly

.

First Patient Dosed in Australia in ATG-101 First-in-Human Trial

  • Written by PR Newswire Asia - Daily Bulletin Au RSS

Study to evaluate ATG-101, a proprietary PD-L1/4-1BB bispecific antibody

Study will enroll patients with Metastatic/Advanced Solid Tumors and Mature B-Cell Non-Hodgkin Lymphomas

First Patient Dosed in Australia in ATG-101 First-in-Human Trial

SHANGHAI AND HONG KONG, Dec. 20, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative global biopharmaceutical company...

Read more: First Patient Dosed in Australia in ATG-101 First-in-Human Trial

Business News

How BSM Law Influences Modern Legal Practices

Business Services Management (BSM) law has been largely overlooked or ignored over the past few decades, but BSM (Business Services Management) law is becoming a central practice area in many modern l...

Daily Bulletin - avatar Daily Bulletin

Why Choosing the Right Labour Hire Company on the Gold Coast Matters for Your Business

Introduction For many businesses across the Gold Coast, staffing remains one of the most significant challenges. The region’s diverse economy, with its mix of tourism, construction, hospitality, and ...

Daily Bulletin - avatar Daily Bulletin

The Importance of Scrap Metal Melbourne Recycling and Car Battery Disposal

In a growing city like Melbourne, sustainability and efficient waste management are continually growing concerns. Of the numerous categories of waste, scrap metal and used vehicle batteries stand out ...

Daily Bulletin - avatar Daily Bulletin

LayBy Deals